Conversion Disorder Clinical Trial
Official title:
Proinflammatory Cytokine Levels in Patients With Conversion Disorder
The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02275000 -
Feasibility Study of Physiotherapy for Functional Motor Symptoms
|
N/A | |
Completed |
NCT00835627 -
Treatment Trial for Psychogenic Nonepileptic Seizures
|
Phase 4 | |
Active, not recruiting |
NCT01422278 -
Rehabilitation of Conversion Gait Disorder
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03441867 -
Neuroimaging Biomarker for Seizures
|
N/A | |
Completed |
NCT03398070 -
Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders
|
||
Completed |
NCT02102906 -
TMS and Attentional Bias in Functional Motor Disorder
|
N/A | |
Completed |
NCT02325544 -
Comparing Different Treatments in Reducing Dissociative Seizure Occurrence
|
N/A | |
Terminated |
NCT02764476 -
Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder
|
N/A | |
Recruiting |
NCT05323344 -
Metacognitive Therapy and Neuro-physiotherapy as a Treatment for Functional Movement Disorders
|
N/A | |
Recruiting |
NCT04097184 -
Efficacy of Dorso-lateral Prefrontal Cortex Stimulation by tDCS in Motor Conversion Disorder Patients
|
N/A | |
Completed |
NCT05219006 -
Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures
|
N/A | |
Completed |
NCT02329626 -
Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder
|
||
Recruiting |
NCT05943652 -
Observational Study on "Functional Overlay" in Patients With Movement Disorders
|
||
Completed |
NCT00159965 -
Treatments for Psychogenic Nonepileptic Seizures (NES)
|
Phase 4 | |
Completed |
NCT05305014 -
Contribution of Inflammation and Neuronal Integrity Markers in Patients With First-episode Conversive Motor Disorder
|